Form SEC STAFF LETTER PIERIS PHARMACEUTICALS,
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Banzai launches $1M public offering of Class A common stock
- FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
- Cango sets 10-for-1 share consolidation effective July 20
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
